| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |